Evolent Health (EVH) EBITDA margin US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA margin, % | ? | 6.13% | 3.24% | -1.26% | 3.32% | 5.94% | 5.42% | |
| Changes by years, y/y, % | +32pp | -3pp | -4pp | +5pp | +3pp | |||
Evolent Health. EBITDA margin, %
Evolent Health. EBITDA margin, changes, pp
Evolent Health (EVH) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -5.94% | 6.13% | 5.73% | 7.55% | 2.49% | 5.42% | |
| Changes by years, y/y, % | -9pp | +1pp | +4pp | +5pp | +8pp | |||
| Changes by quarters, q/q, % | -8pp | +12pp | 0pp | +2pp | -5pp | |||